Hemostasis and Tissue Sealing Agents Market

Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.

Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.

Hemostasis and Tissue Sealing Agents Market contains market size and forecasts of Hemostasis and Tissue Sealing Agents in global, including the following market information:

Global Hemostasis and Tissue Sealing Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hemostasis and Tissue Sealing Agents Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Hemostasis and Tissue Sealing Agents companies in 2021 (%)

The global Hemostasis and Tissue Sealing Agents market was valued at 3662.5 million in 2021 and is projected to reach US$ 5015.6 million by 2028, at a CAGR of 4.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hemostasis Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hemostasis and Tissue Sealing Agents include Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution, Pfizer and CSL Behring, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemostasis and Tissue Sealing Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemostasis and Tissue Sealing Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemostasis and Tissue Sealing Agents Market Segment Percentages, by Type, 2021 (%)

Hemostasis Agents

Tissue Sealing Agents

Global Hemostasis and Tissue Sealing Agents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemostasis and Tissue Sealing Agents Market Segment Percentages, by Application, 2021 (%)

Minimally Invasive Surgery

General Surgery

Others

Global Hemostasis and Tissue Sealing Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hemostasis and Tissue Sealing Agents Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hemostasis and Tissue Sealing Agents revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hemostasis and Tissue Sealing Agents revenues share in global market, 2021 (%)

Key companies Hemostasis and Tissue Sealing Agents sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Hemostasis and Tissue Sealing Agents sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Johnson & Johnson

Baxter

C R Bard

B Braun

Gelita

Integra Life Sciences

Advance Medical Solution

Pfizer

CSL Behring

CryoLife

Zimmer Biomet

Ferrosan Medical Devices

Medtronic

Smith & Nephew

Z-Medica

Cohera Medical

Marine Polymer

Equimedical